Morgan Stanley Maintains Equal-Weight on Exelixis, Lowers Price Target to $57
Benzinga Newsdesk 20 hours ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and lowers the price target from $60 to $57.
Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and lowers the price target from $60 to $57.